What a telehealth membership actually buys

What this comes down to

• Twenty priced lines across eighteen sellers are a recurring fee rather than a drug. The cheapest is $19.99 a month and the dearest is $299.
• Four of them advertise a lower first-month rate than the one that recurs afterward.
• What the fee buys varies: clinician visits, messaging, lab draws, member pricing on the drugs, or nothing you can point at. What it never is, on this roster, is the price of the drug.
• Federal law requires a clear disclosure of material terms before billing information is taken, express informed consent before the charge, and a simple mechanism to stop it.

What the charge actually is

A membership is a recurring platform fee. It buys access to the prescriber and the messaging, sometimes the lab work, sometimes member pricing on the drugs. Of the 385 priced lines on our roster, twenty are one of these rather than a medication, and the drug is billed as its own line.

The names vary and the thing doesn't. Sellers write it as a membership, a clinic membership, a provider support fee, a clinical service and support fee, a care plan. The calculator treats every one of them as a separate recurring charge, because that's what your card sees.

Every recurring fee on the sellers we have read first-hand

The first month is often not the price

Four of those fees advertise one figure and renew at another. The widest gap on the roster right now is LifeMD, advertised at $39 and recurring at $149 — and that's the fee alone, before any medication. The same pattern on medication prices is the single most common thing we find.

What the law requires of a recurring charge

The Restore Online Shoppers' Confidence Act makes it unlawful to charge a consumer through a negative option feature online unless three conditions are met^[1]. It's short enough to read in full, and worth reading, because it's what a bad checkout flow violates.

1. Text that clearly and conspicuously discloses all material terms of the transaction, before your billing information is taken.
2. Your express informed consent before the card is charged.
3. A simple mechanism to stop the recurring charges.

The FTC's 2024 click-to-cancel rule, which would have added specific requirements on top of that, isn't in force. The Commission published a Federal Register notice on February 12, 2026 revising the Negative Option Rule to conform to federal court decisions, and issued an advance notice of proposed rulemaking on March 13, 2026^[2]. So the statute above is the operative floor.

What a membership does not change

It doesn't make a compounded drug an approved one. Compounded drugs aren't reviewed by the FDA for safety, effectiveness or quality before they're marketed, and paying a platform fee doesn't alter that^[3]. The distinction is set out in compounded versus brand.

It doesn't tell you who made your medicine, either. The FDA's own observation is that people buying through telehealth platforms may not know the identity of the compounder that produced the drug, including whether that compounder is appropriately licensed and regulated^[3]. A membership is a relationship with the platform, not with the pharmacy.

And it doesn't answer the FDA's own list of telehealth warning signs. One of them is a company that has no licensed doctor available to answer questions after the medicine arrives^[4]. That's precisely the thing a monthly fee is usually sold as buying, so it's a fair thing to test before the second charge lands.

Three questions worth asking before you subscribe

• Is the medication included, or billed separately? On this roster it is separate, and on several sellers the fee is quoted where a drug price should be.
• What does the fee renew at? Where a first month is discounted, the renewal is the number that matters. Our reviews print both.
• Can you cancel without a phone call? The law requires a simple mechanism. A cancellation that requires reaching a person during business hours is a design choice.

Questions people actually ask

Sources

Every source here was fetched and read for this article, with the identifier taken off the record that came back and the claim it supports written down beside it. All of it was read in September 2026, the same session the rest of this page draws on.

1. 15 U.S.C. §8403 — Negative option marketing on the Internet. Office of the Law Revision Counsel, United States Code, 2026. Source · Document dated September 2026
   The three conditions quoted: a clear and conspicuous disclosure of all material terms before billing information is obtained, express informed consent before the charge, and simple mechanisms to stop recurring charges. The page states the text contains laws in effect on September 2, 2026.
2. Negative Option Rule. Federal Trade Commission, 2026. Source ·
   The rule page lists a Federal Register notice dated February 12, 2026, 'Revision of the Negative Option Rule, Withdrawal of the CARS Rule, Removal of the Non-Compete Rule To Conform These Rules to Federal Court Decisions', and an advance notice of proposed rulemaking dated March 13, 2026 — so the 2024 click-to-cancel rule is not in force.
3. Compounding and the FDA: Questions and Answers. U.S. Food and Drug Administration, 2025. Source · Document dated September 2025
   Compounded drugs are not FDA approved, and consumers who buy compounded drugs online through telehealth platforms may not know the identity of the compounder that produced the drug, including whether it is appropriately licensed and regulated.
4. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. U.S. Food and Drug Administration, 2026. Source · Document dated September 2026
   The agency's telehealth red flags for consumers, including a company that offers medicine at deep discounts or prices that seem too good to be true, and one that does not have a licensed doctor available to answer questions after the medication arrives.